Skip to Main Content

This is a test.

OCC’s interview with Stephanie Gill

This is a test.

Ovarian cancer prevention can save lives now

This is a test.

Ovarian Cancer Canada applauds the government’s commitment to women’s health

“We know the time for research investment is now and we are grateful that ovarian cancer remains a priority in Canada. These funds are critical in continuing the momentum and fueling progress. And OCC will use this important funding to transform lives,” says Tania Vrionis, CEO, OCC.

OCC, our network of researchers, clinicians, and our patient community across Canada, applaud the government’s commitment and investment in women’s health.

This is a test.

A strategic partnership of $1.2M for ovarian cancer treatments

This is a test.

Ovarian Cancer Canada and the Quebec-Clinical Research Organization in Cancer team up to improve access to vital resources

This is a test.

Advocacy in action: Making game-changing PARP Inhibitors accessible for women in Prince Edward Island

This is a test.

Canadian innovation in ovarian cancer research can save the lives of women in Canada and around the world

This is a test.

Clinical Trial: Targeting the targets – investigating an innovative chemotherapy alternative

This is a test.

Research knows no bounds

This is a test.

Prize awarded to researcher whose ovarian cancer vaccines are in preclinical studies funded by Ovarian Cancer Canada